Pharma industry outlook 2026: Trends, priorities and the future
The pharma industry is navigating a landscape defined by scientific breakthroughs, AI-powered transformation and intensifying pricing pressures. In this 2026 outlook, ZS experts explore how leading companies are doubling down on five key priorities—from reimagining R&D with intelligent agents to building direct-to-patient models—to weather disruption and shape the future of healthcare.
